Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue:    
Total revenue $ 31,390 $ 23,955
Cost of revenue 12,268 10,341
Gross profit 19,122 13,614
Research and development costs 12,392 11,709
Sales and marketing expenses 14,478 12,595
General and administrative expenses 11,998 11,756
Operating loss (19,746) (22,446)
Other income (expense):    
Other expense, net (40) (29)
Interest income, net 872 386
Net loss $ (18,914) $ (22,089)
Net loss per share attributable to common stockholders:    
Basic (in dollars per share) $ (0.7) $ (0.9)
Diluted (in dollars per share) $ (0.7) $ (0.9)
Weighted average shares outstanding:    
Basic (in shares) 27,027,692 24,605,212
Diluted (in shares) 27,027,692 24,605,212
Product revenue    
Revenue:    
Total revenue $ 18,626 $ 10,603
Service and other revenue    
Revenue:    
Total revenue $ 12,764 $ 13,352